These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30392091)

  • 1. Repeatability of dynamic contrast enhanced v
    Artzi M; Liberman G; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
    J Neurooncol; 2018 Dec; 140(3):727-737. PubMed ID: 30392091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between treatment-related changes and progressive disease in patients with high grade brain tumors using support vector machine classification based on DCE MRI.
    Artzi M; Liberman G; Nadav G; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
    J Neurooncol; 2016 May; 127(3):515-24. PubMed ID: 26754857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating between Central Nervous System Lymphoma and High-grade Glioma Using Dynamic Susceptibility Contrast and Dynamic Contrast-enhanced MR Imaging with Histogram Analysis.
    Murayama K; Nishiyama Y; Hirose Y; Abe M; Ohyu S; Ninomiya A; Fukuba T; Katada K; Toyama H
    Magn Reson Med Sci; 2018 Jan; 17(1):42-49. PubMed ID: 28515410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
    Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
    Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images.
    Anzalone N; Castellano A; Cadioli M; Conte GM; Cuccarini V; Bizzi A; Grimaldi M; Costa A; Grillea G; Vitali P; Aquino D; Terreni MR; Torri V; Erickson BJ; Caulo M
    Radiology; 2018 Jun; 287(3):933-943. PubMed ID: 29361245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
    Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
    J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma.
    Thomas AA; Arevalo-Perez J; Kaley T; Lyo J; Peck KK; Shi W; Zhang Z; Young RJ
    J Neurooncol; 2015 Oct; 125(1):183-90. PubMed ID: 26275367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software.
    Conte GM; Castellano A; Altabella L; Iadanza A; Cadioli M; Falini A; Anzalone N
    Radiol Med; 2017 Apr; 122(4):294-302. PubMed ID: 28070841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
    Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
    Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histogram analysis of T2*-based pharmacokinetic imaging in cerebral glioma grading.
    Liu HS; Chiang SW; Chung HW; Tsai PH; Hsu FT; Cho NY; Wang CY; Chou MC; Chen CY
    Comput Methods Programs Biomed; 2018 Mar; 155():19-27. PubMed ID: 29512499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cerebral blood volume measurements using dynamic contrast enhancement in comparison to dynamic susceptibility contrast MRI.
    Artzi M; Liberman G; Nadav G; Vitinshtein F; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D
    Neuroradiology; 2015 Jul; 57(7):671-8. PubMed ID: 25845809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: a longitudinal MRI study.
    Artzi M; Bokstein F; Blumenthal DT; Aizenstein O; Liberman G; Corn BW; Ben Bashat D
    Eur J Radiol; 2014 Jul; 83(7):1250-1256. PubMed ID: 24809637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy.
    Lis E; Saha A; Peck KK; Zatcky J; Zelefsky MJ; Yamada Y; Holodny AI; Bilsky MH; Karimi S
    Neurosurg Focus; 2017 Jan; 42(1):E9. PubMed ID: 28041318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
    Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2*-correction in dynamic contrast-enhanced MRI from double-echo acquisitions.
    Kleppestø M; Larsson C; Groote I; Salo R; Vardal J; Courivaud F; Bjørnerud A
    J Magn Reson Imaging; 2014 May; 39(5):1314-9. PubMed ID: 24123598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma.
    Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V
    Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas.
    Piludu F; Marzi S; Pace A; Villani V; Fabi A; Carapella CM; Terrenato I; Antenucci A; Vidiri A
    Neuroradiology; 2015 Dec; 57(12):1269-80. PubMed ID: 26364181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
    Nadav G; Liberman G; Artzi M; Kiryati N; Bashat DB
    J Magn Reson Imaging; 2017 Jan; 45(1):237-249. PubMed ID: 27383624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravoxel incoherent motion MRI in the brain: Impact of the fitting model on perfusion fraction and lesion differentiability.
    Keil VC; Mädler B; Gielen GH; Pintea B; Hiththetiya K; Gaspranova AR; Gieseke J; Simon M; Schild HH; Hadizadeh DR
    J Magn Reson Imaging; 2017 Oct; 46(4):1187-1199. PubMed ID: 28152250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.